Brainstorm Cell Therapeutics Inc
XBER:GHDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Brainstorm Cell Therapeutics Inc
XBER:GHDN
|
US |
|
E
|
EnQuest PLC
SWB:3EQ
|
UK |
|
Secom Co Ltd
TSE:9735
|
JP |
|
A
|
AMMB Holdings Bhd
KLSE:AMBANK
|
MY |
|
N
|
New Stratus Energy Inc
XTSX:NSE
|
CA |
|
Ascencio SCA
XBRU:ASCE
|
BE |
|
Adeia Inc
NASDAQ:ADEA
|
US |
|
Sanofi SA
LSE:0A2V
|
FR |
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
NIB Holdings Ltd
ASX:NHF
|
AU |
|
Magellan Aerospace Corp
TSX:MAL
|
CA |
|
N
|
Norfolk Southern Corp
XMUN:NFS
|
US |
|
D
|
Direct Line Insurance Group PLC
SWB:D1LN
|
UK |
|
G
|
Giglio.Com SpA
MIL:GCOM
|
IT |
|
B
|
Bombardier Inc
OTC:BDRAF
|
CA |
|
Integrated Industries Ltd
BSE:531889
|
IN |
|
China Resources Cement Holdings Ltd
F:C44
|
HK |
|
W
|
Willis Towers Watson PLC
NASDAQ:WTW
|
UK |
|
G
|
Genesis AI Corp
CNSX:AIG
|
CA |
|
Nippon Sanso Holdings Corp
TSE:4091
|
JP |
|
Talen Energy Corp
NASDAQ:TLN
|
US |
|
B
|
Bakrie & Brothers Tbk PT
XMUN:LFU2
|
ID |
|
EVE Energy Co Ltd
SZSE:300014
|
CN |
|
Tristate Holdings Ltd
HKEX:458
|
HK |
Bankruptcy Probability
Brainstorm Cell Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Brainstorm Cell Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
|
9.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
393.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Brainstorm Cell Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Brainstorm Cell Therapeutics Inc has total debt of 1.2m USD. This includes both short-term (1.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
